Monday, June 5, 2023

ACICLOVIR HIKMA 250 mg pdre p sol p perf,,,ACICLOVIR 250 mg pdre p sol p perf (ACICLOVIR HIKMA)



ZOVIRAX 250 mg pdre p sol inj IV:

harmacotherapeutic classification:


Infectiology - Parasitology : Antivirals - Viruses of the Herpes group (HSV, VZV, CMV) : Aciclovir ( IV route).

Classification ATC :

GENERAL ANTIINFECTIVES FOR SYSTEMIC USE : ANTIVIRALS FOR SYSTEMIC USE - DIRECT -ACTING ANTIVIRALS: NUCLEOSIDES AND NUCLEOTIDES, EXCLUDED REVERSE TRANSCRIPTASE INHIBITORS (ACICLOVIR).

Substance:

acyclovir

Excipients:

sodium hydroxide

Excipients with known effect:

NRS with threshold dose:  sodium

Presentation:

ACICLOVIR HIKMA 250 mg Pdr sol perf 10Fl:

  • Cip: 3400930084533
  • Storage conditions: Before opening: < 25° for 24 months
  • List 1
  • Approved for Communities
  • Refund: 65%